HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
$1.58
Makalipas ang Oras ng Trabaho:(0.63%)+0.0100
$1.59
Sarado: Hun 6, 5:30:07 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.52
Sakop ng araw
$1.51 - $1.61
Sakop ng taon
$0.82 - $3.10
Market cap
125.78M USD
Average na Volume
1.20M
P/E ratio
63.71
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.11M | 169.82% |
Gastos sa pagpapatakbo | 6.08M | 1.27% |
Net na kita | -3.62M | 21.24% |
Net profit margin | -35.79 | 70.81% |
Kita sa bawat share | — | — |
EBITDA | -3.80M | 16.21% |
Aktuwal na % ng binabayarang buwis | 3.03% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 34.74M | -28.35% |
Kabuuang asset | 73.89M | -17.74% |
Kabuuang sagutin | 28.68M | -52.22% |
Kabuuang equity | 45.21M | — |
Natitirang share | 79.61M | — |
Presyo para makapag-book | 2.62 | — |
Return on assets | -14.07% | — |
Return on capital | -20.90% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.62M | 21.24% |
Cash mula sa mga operasyon | -5.06M | -220.77% |
Cash mula sa pag-invest | -312.00K | 48.51% |
Cash mula sa financing | 5.08M | — |
Net change in cash | -302.00K | -108.45% |
Malayang cash flow | -3.76M | -175.74% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
213
